Evidence map›Paper›PMID 23226320›Full record

ArticlePloS one2012

Deep clonal profiling of formalin fixed paraffin embedded clinical samples.

Tara Holley, Elizabeth Lenkiewicz, Lisa Evers, Waibhav Tembe, Christian Ruiz, Joel R Gsponer, Cyrill A Rentsch, Lukas Bubendorf, Mark Stapleton, Doug Amorese and 9 more

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Single-Nucleus RNA-Seq: Open the Era of Great Navigation for FFPE Tissue.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Enhancing Tumor Content through Tumor Macrodissection.Journal of visualized experiments : JoVE · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues.Laboratory investigation; a journal of technical methods and pathology · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Tara HolleyClinical Translational Research Division, Translational Genomics Research Institute, Scottsdale, Arizona, United States of America.
Elizabeth Lenkiewicz
Lisa Evers
Waibhav Tembe
Christian Ruiz
Joel R Gsponer
Cyrill A Rentsch
Lukas Bubendorf
Mark Stapleton
Doug Amorese
Christophe Legendre
Heather E Cunliffe
Ann E McCullough
Barbara Pockaj
David Craig
John Carpten
Daniel Von Hoff
Christine Iacobuzio-Donahue
Michael T Barrett

Funding

Validation of Amplified Genes in Pancreatic CancerP01CA109552 · NCI · TRANSLATIONAL GENOMICS RESEARCH INST · PI VON HOFF, DANIEL D · 2005 to 2009
$15.2M
Highly Parallel Supercomputing for Translational ResearchS10RR025056 · NCRR · TRANSLATIONAL GENOMICS RESEARCH INST · PI SUH, EDWARD B · 2008 to 2008
$2.0M
High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma SamplesR21CA137687 · NCI · TRANSLATIONAL GENOMICS RESEARCH INST · PI BARRETT, MICHAEL T · 2010 to 2012
$742k
NCI NIH HHS 1R21CA137687NCI NIH HHS 5P01CA109552-04NCI NIH HHS P01 CA109552NCI NIH HHS R21 CA137687NCRR NIH HHS 1S10RR25056-01NCRR NIH HHS S10 RR025056
6 · The paper itself

Abstract

Formalin fixed paraffin embedded (FFPE) tissues are a vast resource of annotated clinical samples. As such, they represent highly desirable and informative materials for the application of high definition genomics for improved patient management and to advance the development of personalized therapeutics. However, a limitation of FFPE tissues is the variable quality of DNA extracted for analyses. Furthermore, admixtures of non-tumor and polyclonal neoplastic cell populations limit the number of biopsies that can be studied and make it difficult to define cancer genomes in patient samples. To exploit these valuable tissues we applied flow cytometry-based methods to isolate pure populations of tumor cell nuclei from FFPE tissues and developed a methodology compatible with oligonucleotide array CGH and whole exome sequencing analyses. These were used to profile a variety of tumors (breast, brain, bladder, ovarian and pancreas) including the genomes and exomes of matching fresh frozen and FFPE pancreatic adenocarcinoma samples.

Indexed as

Paraffin EmbeddingTissue FixationAdenocarcinomaCloning, MolecularComparative Genomic HybridizationFormaldehydeHigh-Throughput Nucleotide SequencingHumansPancreatic NeoplasmsSequence Analysis, DNAFormaldehyde

Identifiers

PMID23226320
PMCPMC3511535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.